Initial experience with BPaL-based regimens to treat multidrug-resistant TB

Int J Tuberc Lung Dis. 2023 Aug 1;27(8):649-650. doi: 10.5588/ijtld.23.0185.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents* / therapeutic use
  • Clinical Protocols
  • Diarylquinolines
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Diarylquinolines